| 002498 (1984) |
N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon] | Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers |
| 001F22 (1993) |
Y. Okuno [Japon] ; Y. Isegawa ; F. Sasao ; S. Ueda | A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains |
| 002450 (1985) |
Kuniaki Nerome [Japon] ; Yasuyuki Yoshioka [Japon] ; Shinichi Sakamoto [Japon] ; Hisao Yasuhara [Japon] ; Akira Oya [Japon] | Characteristics of a swine recombinant influenza virus isolated in 1980: recombination between swine and the earliest Hong Kong (H3N2) viruses |
| 002D89 (????) |
N A Ivanova ; E B Grinbaum ; L Iu Taros ; T Ia Luzianina ; A A Smorodintsev | [Serological foundation for the persisting circulation of influenza viruses A(HON1) and A(H2N2) among children]. |
| 002E02 (????) |
I M Isma Lova ; E I Isaeva ; Z I Rovnova | [Monoreceptor antibodies to the hemagglutinin antigenic determinants of influenza viruses H2N2 and their virus-neutralizing activity]. |
| 000730 (2014) |
Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie] | Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus |
| 001F93 (1991) |
P W Gill ; A M Murphy ; A L Cunningham | Influenza A(H1N1): a widening spectrum? |
| 002129 (1990) |
G. N. Milligan [États-Unis] ; L. A. Morrison [États-Unis] ; J. Gorka ; V. L. Braciale [États-Unis] ; T. J. Braciale [États-Unis] | The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen |
| 002406 (1986) |
J. R. Bennink ; J. W. Yewdell ; G. L. Smith ; B. Moss | Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes |
| 002418 (1985) |
R. Pyhã Lã | Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses. |
| 002420 (1985) |
D. B. Golubev [Russie] ; G. I. Karpukhin [Russie] ; S. S. Galitarov [Russie] ; G. M. Denisov [Russie] | Type A influenza (H2N2) viruses isolated in Leningrad in 1980 |
| 002496 (1984) |
W. Graeme Laver [République populaire de Chine] ; Robert G. Webster [République populaire de Chine] ; C. M. Chu [République populaire de Chine] | Summary of a Meeting on the Origin of Pandemic Influenza Viruses |
| 002523 (1984) |
A. Yamada [États-Unis] ; L. E. Brown [États-Unis] ; R. G. Webster [États-Unis] | Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: Influence of receptor specificity |
| 002569 (1983) |
K. Nerome ; S. Sakamoto ; N. Yano ; T. Yamamoto ; S. Kobayashi ; R G Webster ; A. Oya | Antigenic characteristics and genome composition of a naturally occurring recombinant influenza virus isolated from a pig in Japan. |
| 002641 (1982) |
B L Lu ; R G Webster ; V S Hinshaw | Failure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions. |
| 002784 (1980) |
G Q Liu ; X C Gong ; J M Zhu ; G F Ren ; R L Fan ; W Q Ruan | Antigenic relationship between H1 and H2 of influenza A virus. |
| 002B01 (1976) |
J M Gwaltney | The use of live attenuated influenza vaccine ts-1(E) in man. |
| 002C03 (1974) |
G. C. Schild ; J. S. Oxford ; W. R. Dowdle ; M. Coleman ; M. S. Pereira ; P. Chakraverty | Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic `drift' for the Hong Kong virus |
| 002D76 (????) |
F G Nagieva ; N I Krasnova ; V G Nikulina ; O G Andzhaparidze | [The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection]. |
| 002E25 (????) |
E I Isaeva ; Z I Rovnova ; R Ia Podcherniaeva | [Functional activity of monoclonal and monospecific antibodies in the interaction with antigenic sites of influenza virus hemagglutinin]. |
| 000522 (2015) |
Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie] | Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers |
| 000653 (2014) |
Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni] | The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency. |
| 000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
| 000A27 (2012) |
Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo Icardi | Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. |
| 000D60 (2011) |
Nobuko Ohshima [Japon] ; Yoshitaka Iba [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu Kurosawa [Japon] | Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5 |
| 000D63 (2011) |
Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada] | Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age |
| 000F91 (2010) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets |
| 001062 (2009) |
Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie] | Pandemic Vaccine Preparedness—Have We Left Something Behind? |
| 001132 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. |
| 001225 (2008) |
Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky | Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). |
| 001660 (2004) |
N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. Saenger | Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. |
| 001A96 (1998) |
A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni] | Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2) |
| 001C00 (1996) |
H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. Isegawa | The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region. |
| 001E47 (1994) |
M. Tamura [États-Unis] ; R. G. Webster ; F. A. Ennis [États-Unis] | Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses |
| 001F27 (1992) |
S Q Li [États-Unis] ; J L Schulman ; T. Moran ; C. Bona ; P. Palese | Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. |
| 002064 (1990) |
H. Závadová [République tchèque] ; E. Domorázková ; J. Skovránková ; M. Vodicková ; P. Ragac ; V. Vonka | [Reactivity and immunologic activity of polyvalent split influenza vaccine in children]. |
| 002128 (1990) |
I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. Couch | Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes |
| 002133 (1989) |
N P Arbatski ; A P Zheltova ; D V Iurtov ; V A Derevitskaia ; N K Kochetkov | [Successive isolation of hemagglutinin and neuraminidase from influenza virus A/Kransnodar/101/59 (H2N2) using bromelain]. |
| 002225 (1988) |
A. N. Slepushkin [Russie] ; P. A. Patriarca [États-Unis] ; N. P. Obrosova-Serova [Russie] ; M. W. Harmon [États-Unis] ; L. N. Kupryashina [Russie] ; S. G. Cheshik [Russie] ; R. B. Vartanyan [Russie] ; G. I. Alexandrova [Russie] ; F. I. Polezhaev [Russie] ; N. I. Lonskaya [Russie] ; B. V. Yagodovskii [Russie] ; A. P. Kendal [États-Unis] ; V. M. Zhdanov [Russie] | Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain |
| 002231 (1988) |
M. H. Pritchard [Royaume-Uni] ; N. Matthews [Royaume-Uni] ; Julia Munro [Royaume-Uni] | ANTIBODIES TO INFLUENZA A IN A CLUSTER OF CHILDREN WITH JUVENILE CHRONIC ARTHRITIS |
| 002301 (1987) |
N. Masurel [Pays-Bas] | Influenza A and B antibody status in Tanzania |
| 002341 (1986) |
M H Snyder ; M L Clements ; R F Betts ; R. Dolin ; A J Buckler-White ; E L Tierney ; B R Murphy | Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. |
| 002382 (1986) |
M. E. Andrew [Australie] ; B. E. H. Coupar [Australie] ; G. L. Ada [Australie] ; D. B. Boyle [Australie] | Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants |
| 002482 (1984) |
G I Karpukhin ; T L Popova ; L S Karpova ; L M Tsybalova ; G M Denisov | [Antigenic anachronism of the influenza A(H2N2) viruses in Leningrad in 1980. I. The epidemiological and serological characteristics of the influenzal infection caused by A/Leningrad/80 (H2N2) viruses]. |
| 002541 (1984) |
K. Nerome [Japon] ; Y. Yoshioka [Japon] ; C. A. Torres [Japon] ; A. Oya [Japon] ; P. Bachmann [Allemagne] ; K. Ottis [Allemagne] ; R. G. Webster [États-Unis] | Persistence of Q strain of H2N2 influenza virus in avian species: Antigenic, biological and genetic analysis of avian and human H2N2 viruses |
| 002584 (1983) |
Clayton W. Naeve [États-Unis] ; Robert G. Webster [États-Unis] ; Virginia S. Hinshaw [États-Unis] | Phenotypic variation in influenza virus reassortants with identical gene constellations |
| 002643 (1982) |
F I Polezhaev ; L M Garmashova ; T A Koval ; G P Taranova ; N V Topuriya ; G I Aleksandrova | Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus. |
| 002682 (1982) |
David C. Jackson [États-Unis] ; R. G. Webster [États-Unis] | A topographic map of the enzyme active center and antigenic sites on the neuraminidase of influenza virus A/Tokyo/3/67 (H2N2) |
| 002955 (1979) |
W. M. Marine ; J. E. Thomas | Antigenic memory to influenza A viruses in man determined by monovalent vaccines. |
| 002971 (1978) |
W. J. J. Anker ; A. K. Bakker ; N. Masurel | Cross-Protection in Mice After Immunization with H2N2, H3N2, and Heq2Neq2 Influenza Virus Strains |
| 002A21 (1978) |
J. Drescher [Allemagne] | Description of a technique for the analysis of antineuraminidase antibodies oriented to H2N2 and H3N2 influenza virus strains |
| 002B03 (1976) |
V M Stealey ; D. Mccahon ; D S Freestone | Preparation and characterization of live recombinant influenza vaccine. |
| 002B49 (1976) |
J. Drescher [Allemagne] ; U. Desselberger [Allemagne] | Kinetics of reactions of antihemagglutinin and antineuraminidase antibodies with H2N2 and H3N2 influenza virus strains and description of a modification of the photometric ACU method for titration of antineuraminidase antibodies |
| 002D79 (????) |
Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov | [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice]. |
| 002D84 (????) |
E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko | [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. |
| 002D96 (????) |
F G Nagieva ; V G Nikulina ; E I Kuznetsova ; I B Koptiaeva ; N I Krasnova ; O N Ageeva ; O G Andzhaparidze | [Preparation and properties of monoclonal antibodies to influenza virus A/Krasnodar/101/59 (H2N2)]. |
| 002E05 (????) |
V M Zhdanov ; A N Slepushkin ; L M Kupriashina ; V V Ritova ; L V Feklisova | [Level of antibodies to influenza viruses A and B in the blood sera of children under 13]. |
| 002E13 (????) |
M V Sergeeva ; V V Kuznetsov ; M A Kas'Ianenko ; A A Shaldzhian ; I A Repko ; M V Potapchuk ; Iu R. Romanova ; L M Tsybalova | [Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection]. |
| 002E26 (????) |
T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko | [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype]. |
| 002E42 (????) |
I M Isma Lova ; E I Isaeva | [Antigenic composition of the hemagglutinins of influenza viruses H2N2]. |
| 002E45 (????) |
Z. Nikolova ; L Ia Zakstel'Skaia ; R. Kotseva ; E V Molibog | [Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)]. |
| 000042 (2019) |
M. Linster [Pays-Bas, Singapour] ; E. J. A. Schrauwen [Pays-Bas] ; S. Van Der Vliet [Pays-Bas] ; D. F. Burke [Royaume-Uni] ; P. Lexmond [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; D. J. Smith [Royaume-Uni] ; S. Herfst [Pays-Bas] ; B. F. Koel [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas] | The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses |
| 000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
| 000176 (2018) |
Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines |
| 000420 (2016) |
Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde] | Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses. |
| 000439 (2016) |
Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. |
| 000531 (2015) |
Milton Thomas [États-Unis] ; Zhao Wang [États-Unis] ; Chithra C. Sreenivasan [États-Unis] ; Ben M. Hause [États-Unis] ; Gourapura J Renukaradhya [États-Unis] ; Feng Li [États-Unis] ; David H. Francis [États-Unis] ; Radhey S. Kaushik [États-Unis] ; Mahesh Khatri [États-Unis] | Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs. |
| 000565 (2015) |
Ankita Malik [Inde] ; V Vamsee Aditya Mallajosyula [Inde] ; Nripendra Nath Mishra [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde] | Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein. |
| 000577 (2015) |
Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie] | Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. |
| 000741 (2014) |
Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis] | Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model |
| 000825 (2013) |
Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. Wilson | Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin |
| 000833 (2013) |
Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. Gray | Serological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers. |
| 000A50 (2012) |
Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto Burioni | Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines |
| 000C34 (2011) |
Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine] | Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A |
| 000C81 (2011) |
Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. Katz | Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. |
| 000C94 (2011) |
Nicola Clementi [Italie] ; Donata De Marco ; Nicasio Mancini ; Laura Solforosi ; Guisella J. Moreno ; Larisa V. Gubareva ; Vasiliy Mishin ; Andrea Di Pietro ; Elisa Vicenzi ; Antonio G. Siccardi ; Massimo Clementi ; Roberto Burioni | A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. |
| 000E24 (2010) |
Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis] | Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes |
| 000E59 (2010) |
Philippe R S. Lagacé-Wiens [Canada] ; Ethan Rubinstein ; Abba Gumel | Influenza epidemiology--past, present, and future. |
| 000E85 (2010) |
Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio Ledesma | Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. |
| 000E97 (2010) |
Seyyed Mahmoud Ebrahimi [Iran] ; Majid Tebianian ; Hadi Toghyani ; Arash Memarnejadian ; Hamid Reza Attaran | Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris. |
| 000F07 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao | A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. |
| 001125 (2009) |
Irina A. Leneva [Royaume-Uni] ; Rupert J. Russell ; Yury S. Boriskin ; Alan J. Hay | Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. |
| 001250 (2008) |
Michelle Roti [États-Unis] ; Junbao Yang ; Deanna Berger ; Laurie Huston ; Eddie A. James ; William W. Kwok | Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. |
| 001252 (2008) |
Joo Sub Lee [Corée du Sud] ; Hyun Soo Kim ; Sang Heui Seo | Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine. |
| 001391 (2007) |
Jae Min Song [Corée du Sud] ; Ki Duk Park ; Kwang Hee Lee ; Young Ho Byun ; Ju Hee Park ; Sung Han Kim ; Jae Hong Kim ; Baik Lin Seong | Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. |
| 001479 (2006) |
Annette Schrauder ; Brunhilde Schweiger ; Udo Buchholz ; Walter Haas ; Daniel Sagebiel ; Adrienne Guignard ; Wiebke Hellenbrand | Laboratory exposure to influenza A H2N2, Germany, 2004-2005. |
| 001496 (2006) |
Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. Seong | Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. |
| 001569 (2006) |
J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis] | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential |
| 001648 (2005) |
S. Al Faress [France] ; G. Cartet [France] ; O. Ferraris [France] ; H. Norder [France] ; M. Valette [France] ; B. Lina [France] | Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002. |
| 001872 (2001) |
M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie] | Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice |
| 001994 (1999) |
Jon D. Reuter [États-Unis] ; Andrzej Myc [États-Unis] ; Michael M. Hayes [États-Unis] ; Zhonghong Gan [États-Unis] ; Rene Roy [États-Unis] ; Dujie Qin [États-Unis] ; Rui Yin [États-Unis] ; Lars T. Piehler [États-Unis] ; Roseita Esfand [États-Unis] ; Donald A. Tomalia [États-Unis] ; James R. Baker [États-Unis] | Inhibition of Viral Adhesion and Infection by Sialic-Acid-Conjugated Dendritic Polymers |
| 001A43 (1998) |
J. Jameson [États-Unis] ; J. Cruz ; F A Ennis | Human cytotoxic T-lymphocyte repertoire to influenza A viruses. |
| 001B24 (1997) |
O. Andersen [Danemark] ; K. Vilsgaard Ravn ; I. Juul S Rensen ; G. Jonson ; E. Holm Nielsen ; S E Svehag | Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. |
| 001B26 (1997) |
P. Zheng [États-Unis] ; Y. Liu | Costimulation by B7 modulates specificity of cytotoxic T lymphocytes: a missing link that explains some bystander T cell activation. |
| 001B99 (1996) |
W. Cao [États-Unis] ; B A Myers-Powell ; T J Braciale | The weak CD8+ CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. |
| 001C95 (1995) |
M. Lipkind [Israël] ; E. Shihmanter | Antigenic heterogeneity of N2 neuraminidases of avian influenza viruses isolated in Israel. |
| 001D33 (1995) |
G. A. Tannock [Australie] ; J. R. Romanova [Russie] ; J. A. Paul [Australie] | The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene |
| 001E15 (1994) |
M. A. Ball [États-Unis] ; T. Utsunomiya [États-Unis] ; K. Ikemoto [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice |
| 001E35 (1994) |
Innocent N. Mbawuike [États-Unis] ; Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Christopher S. Jones [États-Unis] ; Thomas R. Cate [États-Unis] ; Robert B. Couch [États-Unis] | Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein |
| 001E68 (1993) |
Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis] | Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge |
